Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity

Pancreatic ductal adenocarcinoma behaves aggressively, with surgically resectable disease having the best chance of long-term survival. Recurrence after surgery and adjuvant therapy is commonly due to distant metastatic disease and is typically managed with systemic therapies, not surgery. We presen...

Full description

Bibliographic Details
Main Authors: Luke D. Rothermel MD, MPH, Carolina Strosberg MD, Barbara A. Centeno MD, Mokenge P. Malafa MD
Format: Article
Language:English
Published: SAGE Publishing 2020-02-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/1073274820904042
id doaj-af3b3d2f3ac348c987585177c4a9a577
record_format Article
spelling doaj-af3b3d2f3ac348c987585177c4a9a5772020-11-25T03:04:42ZengSAGE PublishingCancer Control1073-27482020-02-012710.1177/1073274820904042Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic EntityLuke D. Rothermel MD, MPH0Carolina Strosberg MD1Barbara A. Centeno MD2Mokenge P. Malafa MD3 Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Division of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAPancreatic ductal adenocarcinoma behaves aggressively, with surgically resectable disease having the best chance of long-term survival. Recurrence after surgery and adjuvant therapy is commonly due to distant metastatic disease and is typically managed with systemic therapies, not surgery. We present a rare case of an isolated gastric metastasis due to endoscopic ultrasound-guided with fine-needle aspiration (EUS-FNA) needle tract seeding that was managed surgically. Treatment was informed by input from a mutlidisciplinary team of medical, surgical, and radiation oncologists, radiologists, and pathologists. Rising carbohydrate antigen (CA)19-9 levels suggested disease recurrence, but the tumor’s unusual location and slow growth made diagnosing the cause difficult, resulting in the late identification of the tumor. Palliative resection was performed, rending the patient with no evidence of disease followed by normalized CA19-9 levels. This case highlights the importance of multidisciplinary decision-making in detecting and treating the uncommon but significant tumor seeding with EUS-FNA biopsies in pancreatic ductal adenocarcinoma.https://doi.org/10.1177/1073274820904042
collection DOAJ
language English
format Article
sources DOAJ
author Luke D. Rothermel MD, MPH
Carolina Strosberg MD
Barbara A. Centeno MD
Mokenge P. Malafa MD
spellingShingle Luke D. Rothermel MD, MPH
Carolina Strosberg MD
Barbara A. Centeno MD
Mokenge P. Malafa MD
Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
Cancer Control
author_facet Luke D. Rothermel MD, MPH
Carolina Strosberg MD
Barbara A. Centeno MD
Mokenge P. Malafa MD
author_sort Luke D. Rothermel MD, MPH
title Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
title_short Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
title_full Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
title_fullStr Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
title_full_unstemmed Case Report of Isolated Gastric Metastasis of Pancreatic Cancer From a Diagnostic Biopsy: Management of a Rare Oncologic Entity
title_sort case report of isolated gastric metastasis of pancreatic cancer from a diagnostic biopsy: management of a rare oncologic entity
publisher SAGE Publishing
series Cancer Control
issn 1073-2748
publishDate 2020-02-01
description Pancreatic ductal adenocarcinoma behaves aggressively, with surgically resectable disease having the best chance of long-term survival. Recurrence after surgery and adjuvant therapy is commonly due to distant metastatic disease and is typically managed with systemic therapies, not surgery. We present a rare case of an isolated gastric metastasis due to endoscopic ultrasound-guided with fine-needle aspiration (EUS-FNA) needle tract seeding that was managed surgically. Treatment was informed by input from a mutlidisciplinary team of medical, surgical, and radiation oncologists, radiologists, and pathologists. Rising carbohydrate antigen (CA)19-9 levels suggested disease recurrence, but the tumor’s unusual location and slow growth made diagnosing the cause difficult, resulting in the late identification of the tumor. Palliative resection was performed, rending the patient with no evidence of disease followed by normalized CA19-9 levels. This case highlights the importance of multidisciplinary decision-making in detecting and treating the uncommon but significant tumor seeding with EUS-FNA biopsies in pancreatic ductal adenocarcinoma.
url https://doi.org/10.1177/1073274820904042
work_keys_str_mv AT lukedrothermelmdmph casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity
AT carolinastrosbergmd casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity
AT barbaraacentenomd casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity
AT mokengepmalafamd casereportofisolatedgastricmetastasisofpancreaticcancerfromadiagnosticbiopsymanagementofarareoncologicentity
_version_ 1724680219793555456